CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- 8-K Event Agreement ended · Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Agreement ended · Other events
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Auditor change
- 8-K Event Material agreement · Executive or director change · Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Shareholder vote results
- 8-K/A Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Executive or director change
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K/A Event Exhibits
- 8-K Event Material agreement · Agreement ended · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
Page 1 of 12 · 227 filings